HTBX: HS-110 Phase 2 Interim Data Yahoo! Finance USA, 16 Feb 2021 HS-110 Interim Data Heat Biologics, Inc. (NASDAQ:HTBX) announced positive interim survival data for its Phase II trial of HS-110…